The AHR pathway represses TGFß-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. (2020)
Attributed to:
A BMI1/CHD7 signature in medulloblastoma with poor prognosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-56876-z
PubMed Identifier: 31924815
Publication URI: http://europepmc.org/abstract/MED/31924815
Type: Journal Article/Review
Volume: 10
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322